Company news
Orasure Technologies, Inc. (NASDAQ:OSUR) news
Every Orasure Technologies, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
OraSure Announces Second Quarter 2026 Financial Results
August 5, 2026
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
July 22, 2026
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
July 21, 2026
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
June 11, 2026
Challenged Athletes Foundation and Össur Advance Power in Motion with New Sports Prosthetic Grants and Mobility Clinics Nationwide
May 14, 2026
OraSure Announces First Quarter 2026 Financial Results
May 6, 2026
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
April 22, 2026
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
April 16, 2026
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Un...
March 17, 2026
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
March 17, 2026
OraSure Announces Fourth Quarter 2025 Financial Results
February 25, 2026
OraSure to Launch OraQuick™ HIV Self-Test in Canada
February 10, 2026
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
February 9, 2026
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
January 15, 2026
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
January 15, 2026
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
January 5, 2026
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
December 17, 2025
OraSure to Participate in Upcoming Investor Conference
November 17, 2025
OraSure Announces Third Quarter 2025 Financial Results
November 5, 2025
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
October 29, 2025
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
October 28, 2025
OraSure Announces Second Quarter 2025 Financial Results
August 5, 2025
OraSure Appoints Anne Messing as Chief Commercial Officer
August 4, 2025
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
July 21, 2025
OraSure Launches Novel Blood Collection Device for Proteomic Research
July 10, 2025
OraSure Announces First Quarter 2025 Financial Results
May 7, 2025
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
April 23, 2025
OraSure Announces $40 Million Stock Repurchase Program
March 24, 2025
OraSure Reports Fourth Quarter 2024 Financial Results
February 25, 2025
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
February 14, 2025
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
January 7, 2025
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
January 7, 2025
OraSure to Present at the J.P Morgan Healthcare Conference
January 7, 2025
OraSure Technologies Acquires Sherlock Biosciences
December 19, 2024
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
December 2, 2024
OraSure Reports Q3 ’24 Revenue of $39.9 Million
November 6, 2024
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
October 22, 2024
OraSure Technologies Elects Jack Kenny to the Board of Directors
September 9, 2024
OraSure Reports Q2 ’24 Revenue of $54.3 Million
August 6, 2024
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
July 22, 2024
OraSure Technologies Supports National HIV Testing Day
June 27, 2024
OraSure Reports Q1 ’24 Revenue of $54.1 Million
May 8, 2024
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
April 22, 2024
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
February 27, 2024
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
February 13, 2024
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
January 4, 2024
OraSure to Participate in Upcoming Investor Conferences
November 13, 2023
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
November 7, 2023
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
October 23, 2023
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
August 3, 2023